ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,099.96
1.02%
Dow Jones
38,239.66
0.40%
US Dollar vs MXN
17.1601
0.00%
Brent Oil
88.165
0.00%
Bitcoin
63,432.91
-0.48%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Precision BioSciences Inc (DTIL)

  7. Precision BioSciences Inc (DTIL) Noticias

DTIL Precision BioSciences Inc

9.70
-0.02 (-0.21%)
26 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Precision BioSciences Inc DTIL NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.02 -0.21% 9.70 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
9.65 9.38 10.00 9.38 9.72
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
16/4/202415:15BWPrecision BioSciences Announces Return of Programs and..
27/3/202405:45BWPrecision BioSciences Reports Fourth Quarter and Fiscal Year..
20/3/202415:30BWPrecision BioSciences to Report Fourth Quarter and Fiscal..
19/3/202406:00BWPrecision BioSciences Presents Preclinical Data Highlighting..
06/3/202407:45BWPrecision BioSciences Announces MHRA Approval for Partner..
01/3/202407:00EDGAR2Form 8-K - Current report
01/3/202405:30BWPrecision BioSciences Announces $40.0 Million Offering of..
01/3/202405:00EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
29/2/202416:19EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/2/202415:01BWPrecision BioSciences Announces Proposed Public Offering of..
20/2/202406:00BWPrecision BioSciences Announces Non-Exclusive Patent License..
14/2/202406:00BWPrecision BioSciences Receives Pre-IND Feedback from US FDA..
13/2/202407:29EDGAR2Form 8-K - Current report
13/2/202406:00BWPrecision BioSciences Promotes Naresh Tanna to Vice..
12/2/202410:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202406:00BWPrecision BioSciences Receives Initial $7.5 Million Cash..
09/2/202406:00BWPrecision BioSciences to Effect a Reverse Stock Split
23/1/202418:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202418:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202418:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202418:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202418:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202416:29EDGAR2Form 8-K - Current report
23/1/202415:27EDGAR2Form 144 - Report of proposed sale of securities
22/1/202414:46EDGAR2Form 144 - Report of proposed sale of securities
22/1/202414:42EDGAR2Form 144 - Report of proposed sale of securities
22/1/202414:42EDGAR2Form 144 - Report of proposed sale of securities
19/1/202406:30EDGAR2Form 8-K - Current report
12/1/202407:00EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
11/1/202407:31EDGAR2Form 8-K - Current report
09/1/202408:20APSBiotech Massively Bid Up Before Opening Bell
09/1/202406:00BWPrecision BioSciences Completes License Deal with TG..
22/12/202307:12EDGAR2Form 8-K - Current report
13/12/202307:20BWPrecision BioSciences Announces Approval of First Clinical..
04/12/202315:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
04/12/202315:30EDGAR2Form DEF 14A - Other definitive proxy statements
04/12/202306:00BWPrecision BioSciences Announces Publication in Nature..
30/11/202306:00BWPrecision BioSciences to Present at Hep-DART 2023
28/11/202306:00BWPrecision BioSciences Announces Grant of Inducement Award..
13/11/202306:05BWPrecision BioSciences Presents Late-Breaking Data..
10/11/202306:00BWPrecision BioSciences to Present at Upcoming Sidoti..
09/11/202306:00BWPrecision BioSciences Announces Late-Breaking Poster..
07/11/202306:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202306:15EDGAR2Form 8-K - Current report
07/11/202306:00BWPrecision BioSciences Reports Third Quarter 2023 Financial..
06/11/202316:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/11/202316:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/11/202316:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202314:46EDGAR2Form 144 - Report of proposed sale of securities
03/11/202314:44EDGAR2Form 144 - Report of proposed sale of securities

Su Consulta Reciente

NASDAQ
DTIL
Precision BioSciences
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados